Technology Platforms

Tapping into its scientific team’s broad expertise in novel drug delivery formulations, Kashiv has created new compound-specific and platform technologies for maximum effectiveness. The company has developed several novel and proprietary technology platforms including:

Abuse Deterrent Overdose Protection Technology (iADOPT™)

Advanced abuse deterrent technology based on physical/chemical barriers to prevent manipulation of the dosage form to resist intravenous, intranasal, and multiple pill abuse.
CLICK TO LEARN MORE

BIOMAXX®

Formulation technologies to maximize the bioavailability of poorly soluble drugs to improve therapeutic performance.
CLICK TO LEARN MORE

Enhanced Absorption Controlled Release (ENCORE™)

Controlled release technology applicable to a wide range of poorly soluble drugs to improve site-specific gastrointestinal absorption and reduce dose.
CLICK TO LEARN MORE

Fast Acting Sublingual Technology (FAST™)

Sublingual formulations, including orally disintegrating tablets, based on nano-amorphous and particle engineering technologies that allow absorption in the oral cavity while reducing the loss of drug due to high first-pass effect.
CLICK TO LEARN MORE

Long Acting Depot Injections (LOAD™)

Long-acting subcutaneous or intramuscular injection to control symptoms of chronic diseases and improve patient compliance.
CLICK TO LEARN MORE

  • Preventing drug misuse and overdose
  • Controlled release of poorly soluble drugs
  • Maximize bioavailability of poorly absorbed drugs
  • Rapid onset of action for breakthrough conditions